Lead researcher: Crohn’s & Colitis UK
Lead researcher: Crohn’s & Colitis UK
Our Life in Lockdown survey ran during June and July - an incredible 7,666 people with Crohn’s and Colitis took part to help us understand the impact of the coronavirus pandemic. Here are some of the key results:
For more information on these results, visit our news item.
The CLARITY trial is looking at the impact of infliximab and vedolizumab on COVID-19 infection, vaccination and immune response in people with Crohn’s or Colitis.
Researchers wanted to find out how people with chronic pain (i.e., pelvic, stomach, back, neck, shoulder, nerve pain etc.) were affected by the pandemic.
Early in the pandemic, a research team in Australia conducted a global study to see what different groups of people wanted to see measured in COVID-19 clinical trials.
Last updated: 22/07/2026
Our Helpline team can't take calls, chats or ring you back for the rest of the summer. But you can still reach us by email.
If you need to contact the team, please email helpline@crohnsandcolitis.org.uk and we'll answer you as soon as possible.
Thanks for bearing with us.
Please be aware we’re not medically or legally trained. We cannot provide detailed financial or benefits advice or specialist emotional support.
If you need specific medical advice about your condition, your GP or IBD team will be best placed to help.
Would you like to save the changes made to this page?
Your details were successfully saved.